rs41289846

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2

The NM_004798.4(KIF3B):​c.*3009G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0305 in 152,666 control chromosomes in the GnomAD database, including 115 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.030 ( 112 hom., cov: 32)
Exomes 𝑓: 0.076 ( 3 hom. )

Consequence

KIF3B
NM_004798.4 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.39

Publications

2 publications found
Variant links:
Genes affected
KIF3B (HGNC:6320): (kinesin family member 3B) The protein encoded by this gene acts as a heterodimer with kinesin family member 3A to aid in chromosome movement during mitosis and meiosis. The encoded protein is a plus end-directed microtubule motor and can interact with the SMC3 subunit of the cohesin complex. In addition, the encoded protein may be involved in the intracellular movement of membranous organelles. This protein and kinesin family member 3A form the kinesin II subfamily of the kinesin superfamily. [provided by RefSeq, Jul 2008]
KIF3B Gene-Disease associations (from GenCC):
  • retinitis pigmentosa 89
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • ciliopathy
    Inheritance: AD Classification: MODERATE, LIMITED Submitted by: Franklin by Genoox, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0304 (4623/152150) while in subpopulation NFE AF = 0.045 (3063/68016). AF 95% confidence interval is 0.0437. There are 112 homozygotes in GnomAd4. There are 2309 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 4623 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004798.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KIF3B
NM_004798.4
MANE Select
c.*3009G>A
3_prime_UTR
Exon 9 of 9NP_004789.1O15066-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KIF3B
ENST00000375712.4
TSL:1 MANE Select
c.*3009G>A
3_prime_UTR
Exon 9 of 9ENSP00000364864.3O15066-1
KIF3B
ENST00000929131.1
c.*3009G>A
3_prime_UTR
Exon 10 of 10ENSP00000599190.1

Frequencies

GnomAD3 genomes
AF:
0.0304
AC:
4627
AN:
152032
Hom.:
113
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00727
Gnomad AMI
AF:
0.00768
Gnomad AMR
AF:
0.0183
Gnomad ASJ
AF:
0.0150
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.00663
Gnomad FIN
AF:
0.0803
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0450
Gnomad OTH
AF:
0.0201
GnomAD4 exome
AF:
0.0756
AC:
39
AN:
516
Hom.:
3
Cov.:
0
AF XY:
0.0693
AC XY:
23
AN XY:
332
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
6
American (AMR)
AF:
0.00
AC:
0
AN:
2
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.0829
AC:
36
AN:
434
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.0500
AC:
3
AN:
60
Other (OTH)
AF:
0.00
AC:
0
AN:
12
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.0304
AC:
4623
AN:
152150
Hom.:
112
Cov.:
32
AF XY:
0.0310
AC XY:
2309
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.00725
AC:
301
AN:
41516
American (AMR)
AF:
0.0181
AC:
277
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.0150
AC:
52
AN:
3472
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5176
South Asian (SAS)
AF:
0.00663
AC:
32
AN:
4826
European-Finnish (FIN)
AF:
0.0803
AC:
846
AN:
10540
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0450
AC:
3063
AN:
68016
Other (OTH)
AF:
0.0199
AC:
42
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
223
446
670
893
1116
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
64
128
192
256
320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0375
Hom.:
31
Bravo
AF:
0.0245
Asia WGS
AF:
0.00606
AC:
21
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.17
DANN
Benign
0.59
PhyloP100
-1.4
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41289846; hg19: chr20-30922131; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.